Healthcare -
Biotechnology - NASDAQ - US
$ 4.38
-1.13 %
$ 265 M
Market Cap
-3.56
P/E
RZLT - COST OF REVENUE
Cost of Revenue RZLT - Rezolute, Inc.
36 K
LAST VALUE
-62.50%
2 YEAR CAGR
-5.59%
5 YEAR CAGR
-34.28%
10 YEAR CAGR